LEMAITRE VASCULAR, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
LEMAITRE VASCULAR, INC. (LMAT) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.94 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-05
- LEMAITRE VASCULAR, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $1.94M, a 0.46% decline year-over-year.
- LEMAITRE VASCULAR, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $2.09M, a 2.25% increase year-over-year.
- LEMAITRE VASCULAR, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $1.74M, a 8.07% increase year-over-year.
- LEMAITRE VASCULAR, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $1.94M, a 20.82% increase year-over-year.
- LEMAITRE VASCULAR, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $7.83M, a 19.15% increase from fiscal 2024.
- LEMAITRE VASCULAR, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $6.57M, a 23.48% increase from fiscal 2023.
- LEMAITRE VASCULAR, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $5.32M, a 27.46% increase from fiscal 2022.
- LEMAITRE VASCULAR, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $4.17M, a 19.95% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.94M 10-Q · filed 2026-08-05 | $4.03M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $2.09M 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $7.83M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $1.74M 10-Q · filed 2025-11-07 | $3.68M derived: sum of 2 quarters · filed 2026-08-05 | $5.73M derived: sum of 3 quarters · filed 2026-08-05 | |
| 2025-06-30 | $1.94M 10-Q · filed 2026-08-05 | $3.99M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $2.05M 10-Q · filed 2026-08-05 | |||
| 2024-12-31 | $6.57M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $1.61M 10-Q · filed 2025-11-07 | $3.22M derived: sum of 2 quarters · filed 2025-11-07 | $4.83M derived: sum of 3 quarters · filed 2025-11-07 | |
| 2024-06-30 | $1.61M 10-Q · filed 2025-11-07 | $3.22M derived: sum of 2 quarters · filed 2025-11-07 | ||
| 2024-03-31 | $1.61M 10-Q · filed 2025-11-07 | |||
| 2023-12-31 | $5.32M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $1.31M 10-Q · filed 2024-11-08 | $2.63M derived: sum of 2 quarters · filed 2024-11-08 | $3.92M derived: sum of 3 quarters · filed 2024-11-08 | |
| 2023-06-30 | $1.31M 10-Q · filed 2024-11-08 | $2.60M derived: sum of 2 quarters · filed 2024-11-08 | ||
| 2023-03-31 | $1.29M 10-Q · filed 2024-11-08 | |||
| 2022-12-31 | $4.17M 10-K · filed 2025-02-28 | |||
| 2022-09-30 | $1.19M 10-Q · filed 2023-11-07 | $2.32M derived: sum of 2 quarters · filed 2023-11-07 | $3.49M derived: sum of 3 quarters · filed 2023-11-07 | |
| 2022-06-30 | $1.14M 10-Q · filed 2023-11-07 | $2.30M derived: sum of 2 quarters · filed 2023-11-07 | ||
| 2022-03-31 | $1.17M 10-Q · filed 2023-11-07 | |||
| 2021-12-31 | $3.48M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $797.00K 10-Q · filed 2022-11-08 | $1.67M derived: sum of 2 quarters · filed 2022-11-08 | $2.59M derived: sum of 3 quarters · filed 2022-11-08 | |
| 2021-06-30 | $869.00K 10-Q · filed 2022-11-08 | $1.80M derived: sum of 2 quarters · filed 2022-11-08 | ||
| 2021-03-31 | $927.00K 10-Q · filed 2022-11-08 | |||
| 2020-12-31 | $3.02M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $687.00K 10-Q · filed 2021-11-04 | $1.49M derived: sum of 2 quarters · filed 2021-11-04 | $2.27M derived: sum of 3 quarters · filed 2021-11-04 | |
| 2020-06-30 | $803.00K 10-Q · filed 2021-11-04 | $1.58M derived: sum of 2 quarters · filed 2021-11-04 | ||
| 2020-03-31 | $779.00K 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $2.64M 10-K · filed 2022-02-28 | |||
| 2019-09-30 | $655.00K 10-Q · filed 2020-11-06 | $1.35M derived: sum of 2 quarters · filed 2020-11-06 | $2.10M derived: sum of 3 quarters · filed 2020-11-06 | |
| 2019-06-30 | $694.00K 10-Q · filed 2020-11-06 | $1.44M derived: sum of 2 quarters · filed 2020-11-06 | ||
| 2019-03-31 | $746.00K 10-Q · filed 2020-11-06 | |||
| 2018-12-31 | $2.35M 10-K · filed 2021-03-12 | |||
| 2018-09-30 | $537.00K 10-Q · filed 2019-11-08 | $1.17M derived: sum of 2 quarters · filed 2019-11-08 | $1.79M derived: sum of 3 quarters · filed 2019-11-08 | |
| 2018-06-30 | $636.00K 10-Q · filed 2019-11-08 | $1.26M derived: sum of 2 quarters · filed 2019-11-08 | ||
| 2018-03-31 | $621.00K 10-Q · filed 2019-11-08 | |||
| 2017-12-31 | $2.26M 10-K · filed 2020-03-12 | |||
| 2016-12-31 | $1.68M 10-K · filed 2019-03-11 | |||
| 2015-12-31 | $1.42M 10-K · filed 2018-03-09 | |||
| 2014-12-31 | $1.30M 10-K · filed 2017-03-09 | |||
| 2013-12-31 | $1.25M 10-K · filed 2016-03-10 | |||
| 2012-12-31 | $1.21M 10-K · filed 2015-03-18 | |||
| 2011-12-31 | $1.10M 10-K · filed 2014-03-21 | |||
| 2010-12-31 | $967.00K 10-K · filed 2013-03-27 | |||
| 2009-12-31 | $985.00K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |